Our part-time MBA is ranked No. 1 in Australia* and has a strong focus on developing the personal and interpersonal skills required to lead in today’s hyper-connected, global environment.
Established from a generous donation from prominent alumnus Alek Safarian, this scholarship supports emerging leaders in the areas of pharmacy, pharmacology, medicine, nursing or science who demonstrate an interest in the pharmaceutical industry.
The Alek Safarian MBA Scholarship is valued at over $60,000 and covers the full tuition fees for enrolment in the part-time MBA in semester 1, 2021.
The part-time MBA is designed for professionals with 3-5 years of relevant experience looking to either take their career to the next level or change career direction.
You can complete the degree in two to three years of part-time study and it consists of 12 units of study – an integrated core of seven units, an industry capstone and up to four electives chosen by you.
Entrants must register to apply and then complete an application form via our website. The application will include the submission of a statement of motivation.
9am Tuesday 6 October 2020
10am Monday 23 November 2020
Shortlisted applicants are required to attend a discussion forum and submit an assessment piece.
Friday 11 December 2020
Assessment piece due
11.59PM Sunday 13 December 2020
Shortlisted applicants are invited to attend an interview with the judging panel.
To be confirmed
To be confirmed
Applicants need not have applied for the degree prior to applying for the scholarship – however – only those applicants deemed eligible for entry to the part-time MBA via the prevailing admissions processes are eligible to be awarded the scholarship.
Preference will be given to those who have a qualification awarded by the University of Sydney in pharmacy, pharmacology, medicine, nursing or science.
The degree is currently not available to international students requiring a student visa. Current students enrolled in the University of Sydney MBA, University of Sydney employees are not eligible to apply.
*The Australian Financial Review MBA Rankings 2019